MAIA Biotechnology Inc.

Company Profile

MAIA Biotechnology Inc. had its IPO on 2022-07-28 under the ticker symbol MAIA.

The company operates in the Healthcare sector and Biotechnology industry. MAIA Biotechnology Inc. has a staff strength of 18 employees.

Stock update

Shares of MAIA Biotechnology Inc. opened at $1.86 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.75 - $1.88, and closed at $1.8.

This is a +2.27% increase from the previous day's closing price.

A total volume of 47,088 shares were traded at the close of the day’s session.

In the last one week, shares of MAIA Biotechnology Inc. have slipped by -2.7%.

MAIA Biotechnology Inc.'s Key Ratios

MAIA Biotechnology Inc. has a market cap of $25.25 million, indicating a price to book ratio of 2.9571 and a price to sales ratio of 0.

In the last 12-months MAIA Biotechnology Inc.’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures MAIA Biotechnology Inc.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, MAIA Biotechnology Inc.’s operating margin was 0% while its return on assets stood at -113.21% with a return of equity of -268.03%.

In Q2, MAIA Biotechnology Inc.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

MAIA Biotechnology Inc.’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.24 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into MAIA Biotechnology Inc.’s profitability.

MAIA Biotechnology Inc. stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -2.6766. Its price to sales ratio in the trailing 12-months stood at 0.

MAIA Biotechnology Inc. stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$10.27 million

Total Liabilities

$3.27 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

MAIA Biotechnology Inc. ended 2025 with $10.27 million in total assets and $0 in total liabilities. Its intangible assets were valued at $10.27 million while shareholder equity stood at $6.87 million.

MAIA Biotechnology Inc. ended 2025 with $0 in deferred long-term liabilities, $3.27 million in other current liabilities, 1365.00 in common stock, $-52847772.00 in retained earnings and $0 in goodwill. Its cash balance stood at $9.15 million and cash and short-term investments were $9.15 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

MAIA Biotechnology Inc.’s total current assets stands at $9.78 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $386825.00 compared to accounts payable of $1.55 million and inventory worth $0.

In 2025, MAIA Biotechnology Inc.'s operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, MAIA Biotechnology Inc. paid $0 in dividends in 2025.

Other key metrics

Current Trading Price

$1.8

52-Week High

$5.22

52-Week Low

$1.7

Analyst Target Price

$11.75

MAIA Biotechnology Inc. stock is currently trading at $1.8 per share. It touched a 52-week high of $5.22 and a 52-week low of $5.22. Analysts tracking the stock have a 12-month average target price of $11.75.

Its 50-day moving average was $2.07 and 200-day moving average was $3.07 The short ratio stood at 1.49 indicating a short percent outstanding of 0%.

Around 3306.4% of the company’s stock are held by insiders while 138.3% are held by institutions.